All In MedTech

FDA Clearance Tracker · P200023-S007

Zilver Vena Venous Self-Expanding Stent

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 8, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 8, 2024

Approved

Time to decision

104 days

Received Oct 27, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P200023-S007
Device name
Zilver Vena Venous Self-Expanding Stent
Applicant location
Limerick
Received
Oct 27, 2023
Decided
Feb 8, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P200023

Device type

Device class
Class III

Every decision under product code QAN

FDA's approval statement

As written in FDA's record.

changes to the materials used in your delivery system sheath assembly

Source documents

Other decisions for Cook Ireland, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.